4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:医疗设备、医疗耗材、实验仪器、抗体、试剂、诊断等产品
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > peptide > BD Biosciences/Reticulocyte Reagent System/349204
商品详细BD Biosciences/Reticulocyte Reagent System/349204
BD Biosciences/Reticulocyte Reagent System/349204
BD Biosciences/Reticulocyte Reagent System/349204
商品编号: 349204
品牌: bdbiosciences
市场价: ¥0.00
美元价: 0.00
产地: 美国(厂家直采)
公司:
产品分类: 多肽合成
公司分类: peptide
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
Product DetailsRecommended AssayReferences

Description

BD Retic-COUNT™ reagent is intended for determining reticulocytes as a percentage of total erythrocytes in human peripheral blood by a FACSCalibur™, FACSort™, FACScan™, or FACStrak™ flow cytometer. The Retic-COUNT reagent is for in vitro diagnostic use.

Preparation and Storage

1. For in vitro diagnostic use.

2. The Retic-COUNT reagent is light sensitive and must be stored in the dark at 2° to 8°C. Avoid unnecessary exposure of the reagent or reagent/cell mixture to light.

3. Incubation time or temperatures other than those specified can be a source of error.

4. The reagent bottle must be kept well sealed when not in use.

5. When stored at 2° to 8°C, the reagent is stable until the expiration date shown on the label. Do not use after the expiration date.

6. WARNING: The reagent solution contains a nucleotide-reactive material and can be carcinogenic. Handle with care. Avoid contact with skin and mucous membranes.7. The Retic-COUNT reagent contains sodium azide as a preservative; however, care should be taken to avoid microbial contamination, which can cause erroneous results."

  1. Procedures for the Collection of Diagnostic Blood Specimens by Venipuncture: Approved Standard. Villanova, PA: National Committee for Clinical Laboratory Standards; 1991. NCCLS document H3-A3.

  2. Ferguson D, Lee S-F, Gordon, P. Evaluation of reticulocyte counts by flow cytometry in a routine laboratory. Am J Hematol. 1990;33:13-17.

  3. Gustavsson P, Holm J, Wahlen A, et al. Staging of idiopathic myelofibrosis: significance of haemoglobin values and reticulocyte counts. Acta Med Scan. 1985;218:487-91.

  4. Hillman R, Finch C. Erythropoiesis: normal and abnormal. Semin Hematol. 1972;4:327-48.

  5. Jackson A, Warner N. Preparation, staining, and analysis by flow cytometry of peripheral blood leukocytes. In: Rose N, Friedman H, Fahey J, eds. Manual of Clinical Laboratory Immunology. 1986:226-235.

  6. Koepke J, Koepke J. Review: reticulocytes. Clin Lab Haem. 1986;8:169-80.

  7. Lee L, Chen C, Chiu L. Thiazole Orange: a new dye for reticulocyte analysis. Cytometry. 1986;7:508.

  8. Lewis R, Sweet D, ed. Registry of Toxic Effects of Chemical Substances (RTECS). 1983-1984 Cumulative Supplement to the 1981-1982 Edition VI, US DHHS, 1985 (NIOSH Publication 86-103).

  9. Lichtman M, ed. Hematol for Practitioners. Boston: Little Brown & Co; 1978.

  10. Miale J. Laboratory Medicine Hematology. 5th ed. St. Louis: C.V. Mosby, Co; 1977.

  11. National Committee for Clinical Laboratory Standards. Clinical Applications of Flow Cytometry: Quality Assurance and Immunophenotyping of Peripheral Blood Lymphocytes; Tentative Guideline. (H42-T). 1992

  12. National Committee for Clinical Laboratory Standards. Proposed Standard: Method for Reticulocyt eCounting (H16-P). Villanova, PA: The National Committee for Clinical Laboratory Standards.

  13. Savage R, Skoog D, Rabinovich A. Analytical inaccuracy and imprecision in reticulocyte counting: a preliminary report from the College of American Pathologists Reticulocyte Project. Blood Cells. 1985;11:97-112.

  14. Tanke H, Rothbarth P, Vossen J, et al. Flow cytometry of reticulocytes applied to clinical hematology. Blood. 1983;61:1091-97.

  15. Tanke H, Van Vianen P, Emiliani F, et al. Changes in erythropoiesis due to radiation or chemotherapy as studied by flow cytometric determination of peripheral blood reticulocytes. Histochem. 1986;84:544-48.

  16. Williams W, Beutler E, Erslev A, Lichtman M. Hematology. 3rd ed. New York: McGraw-Hill; 1983

品牌介绍
BD是世界上最大的生产和销售医疗设备、医疗系统和试剂的医疗技术公司之一。致力于提高全世界人类的健康水平。BD专注于改进药物治疗,提高传染性疾病诊断的质量和速度,推进新型药物和疫苗的研究与发现。BD公司具有强大的研发能力和世界上最棘手的多种疾病进行斗争的能力。公司于1897年在纽约成立,总部位于美国新泽西州的富兰克林湖,业务遍及全球。公司的业务可分为BD医疗、BD诊断、BD生物科学三大类,生产销售包括医用耗材、实验室仪器、抗体、试剂、诊断等产品。公司的服务对象包括医疗机构,生命科学研究所,临床实验室,工业单位和普通大众。BD has state-of-the-art facilities around the globe that provide an environment that enables our highly talented workforce to be the best at their professions. We hire associates who have a passion and commitment to advancing the world of health. We are always seeking great people to join our company on its journey to greatness.BDRat Granulocytes Pure RP-1  500ug550002BDMs Ig Kpa Lgt Chain FITC 187.1  500ug550007BDICC Fixation Buffer 100mL550011BDMs CD210 NALE 1B1.3a 500ug550019BDMs CD51 Pure RMV-7 100ug550026BDMs CD5 APC 53-7.3 100ug550037BDHu CD62E PE-Cy5 68-5H11 100Tst550041BDHu CD95 Pure EOS9.1  100ug550052BDHam IgG2 Kpa ItCl FITC B81-3 250ug550057BDMs Crry/p65 Pure 1F2 100ug550059BDMs IL-4 Recom Protein 10ug550068BDMs IL-2 Recom Protein 20ug550070BDHu IL-6 Recom Protein 10ug550072BDHu MIP-1 Bta PE D21-1351 100ug550082BDMs IgG1 PE A85-1 100ug550084BDHam IgG2 Kpa ItCl PE B81-3 100ug550086BDHu CD142 Pure HTF-1 100ug550254BDHu CD1d PE CD1d42 100Tst550256BDHu CD73 PE AD2 100Tst550258BDHu CD103 FITC Ber-ACT8 100Tst550260BDMs CD11c APC HL3 100ug550268BDMs CD72b/c Aloatg PE JY/93 100ug550270BDRat CD32 Pure D34-485 500ug550272BDRat CD32 NALE D34-485 500ug550274BDMs CD3e IHC Pure 145-2C11 1mL550277BDMs CD4 IHC Pure H129.19 1mL550280BDMs CD8a IHC Pure 53-6.7 1mL
联络我们
服务热线:4000-520-616
(限工作日9:00-18:00)
QQ :1570468124
手机:18915418616